sumi.news
Search
Following
Sign in
← Back to news
Y
Yahoo Finance
RSS Feed
finance.yahoo.com
finance.yahoo.com/rss
Follow
Latest
Tue Jan 20
India's Tata signs up OpenAI as customer for data centre business
1d
Y
It Is a Stock Picker's Market, Pepperstone's Weston Says
1d
Y
The 2026 Software Stock Sell-Off: AI Disruption Fear, Broken Logic, or Something Else Entirely?
1d
Y
Kirin's Yoshimura on Health Science Business Strategy
1d
Y
What I'm Watching With CubeSmart Stock To See If It Beats The Market
1d
Y
Evercore Notes AbbVie Inc.’s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited
1d
Y
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
1d
Y
Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.’s (DFTX) DT120 in Phase III
1d
Y
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates
1d
Y
Baird Lowers Bright Minds Biosciences Inc. (DRUG) Price Target to $126, Maintains Outperform Rating Ahead of Upcoming Trials
1d
Y
Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)’s Science-Driven Psilocybin Therapies as Key Growth Drivers
1d
Y
RBC Capital Cite GH Research PLC’s (GHRS) Long-Term Sales Potential Following Psychedelics Symposium
1d
Y
Edison International Posts Strong 2025 and Sets 2026–2027 EPS Targets
1d
Y
VivoPower $30M PIPE deal fuels AI data centre growth
1d
Y
Target expands stores as customers get fed up with chaos
1d
Y
Joe Rogan Says Warren Buffett, George Soros Are 'Not As Good As' Nancy Pelosi's Husband In Stock Trading, Thinks Politicians 'Know Something'
1d
Y
IRS Grants Tech, Pharma a Tax Break Boost From Trump Deduction
1d
Y
Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026
1d
Y
2 Utility Stocks to Buy in February
1d
Y
Rising Energy Demand Will Lift This Stock
1d
Y
Cognex CFO Sees Demand Improving but Wants More Proof of a Durable Upcycle at Conference
1d
Y
What Does the Average Retiree Really Get From Social Security?
1d
Y
Before you buy the software and Big Tech dips, take a closer look at this overseas stock market
1d
Y
Bitcoin Caught Between Hawkish Fed and Dovish Warsh
1d
Y
Occidental Cuts Debt and Lifts Dividend After OxyChem Sale
1d
Y
2 Top Artificial Intelligence Stocks to Buy in February
1d
Y
TrueBlue, Inc. Q4 2025 Earnings Call Summary
1d
Y
Rogers Corporation Q4 2025 Earnings Call Summary
1d
Y
Nextdoor Holdings, Inc. Q4 2025 Earnings Call Summary
1d
Y
Jack in the Box Inc. Q1 2026 Earnings Call Summary
1d
Y
Clearwater Paper Corporation Q4 2025 Earnings Call Summary
1d
Y
Where Will Micron Stock Be in 5 Years?
1d
Y
After Years of Buybacks, Big Oil is Drilling Again
1d
Y
Why Applovin Stock Popped Today
1d
Y
TD Cowen Lowers Aurora Innovation (AUR) PT, Cites Soft 2026 Guidance Despite Growth Inflection Outlook
1d
Y
Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery
1d
Y
Wells Fargo Cites Legend Acquisition Uncertainty as Potential Headwind for Genius Sports (GENI) Valuation
1d
Y
CleanSpark (CLSK): Keefe Bruyette Maintains Positive Outlook on Sealy Project Despite ERCOT Batch Study Uncertainty
1d
Y
PagerDuty (PD): Truist Cites AI Narratives, Terminal Value Concerns as Key Drivers for Infrastructure Software
1d
Y
BofA Lowers Teladoc (TDOC) PT on Peer Multiple Compression, Soft Sensor Tower Trends
1d
Y
Needham Initiates Amprius Technologies (AMPX) as Key Pure-Play Unmanned Aerial Systems Supplier
1d
Y
Is Freshworks (FRSH) One of the Best Single Digit Stocks to Buy According to Analysts?
1d
Y
Citi Lowers Snap (SNAP) PT to $6, Cites Persistent Brand Advertising Headwinds
1d
Y
JPMorgan Initiates TIC Solutions (TIC) Highlighting NV5 Integration and Cross-Selling Synergies
1d
Y
Mahindra Selects Mobileye’s (MBLY) EyeQ6 ADAS for Future Vehicle Lineup
1d
Y
Barclays Adjusts ACV Auctions (ACV) Target Amid Momentum in Used Vehicle Market
1d
Y
Is Brighthouse Financial an Underrated Financial Stock Investment Play?
1d
Y
Utz Brands (UTZ) Q4 2025 Earnings Call Transcript
1d
Y
Wells Fargo Cautious on Praxis Precision (PRAX) After Recent Revenue Estimates
1d
Y
End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations
1d
Y
More →
